Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Studies Internationally; First Site to Open in Saudi Arabia; Engages Experienced Local Clinical Research Organization; Plans for Additional Sites at Advanced Stage
Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Studies Internationally; First Site to Open in Saudi Arabia; Engages Experienced Local Clinical Research Organization; Plans for Additional Sites at Advanced Stage
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.